Eco R1 Capital, LLC Cyclerion Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.99 $2.51 Million - $4.8 Million	-1,606,276 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.25 - $7.12 $2.56 Million - $8.09 Million	-1,136,000 Reduced 41.43%	1,606,276 $4.92 Million
Q1 2020 May 15, 2020	BUY	$2.46 - $5.84 $2.29 Million - $5.44 Million	931,276 Added 51.42%	2,742,276 $7.27 Million
Q4 2019 Feb 14, 2020	BUY	$1.8 - $13.43 $1.86 Million - $13.9 Million	1,034,794 Added 133.31%	1,811,000 $4.93 Million
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $7.45 Million - $17.7 Million	776,206 New	776,206 $8.89 Million

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $153M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.